AAOMS 2022 Position Paper update on Medication Related Osteonecrosis of the Jaw by Jill Meyer-Lippert May 14, 2022 Antiangiogenisis Avastin Bisphosphonates Cancer denonsumab dental Dental Oncology medication-related osteonecrosis of the jaw MRONJ oncology oral care Oral Health Oral Hygiene Osteonecrosis prevention survivorship Read the full update by clicking on the image below Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest Offers From Our Partners: